|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o A.P. Pharma Inc., of Redwood City, Calif., completed the sale of about 4.2 million shares of common stock at $3 per share to various institutional investors, raising $12.5 million gross. The offering was made as part of the company's shelf registration statement filed with the SEC. Olympus Securities LLC served as placement agent. The company estimates it will use net proceeds of $11.8 million for clinical trials, research and development expenses and general and administrative expenses. The company focuses on developing and commercializing its bioerodible injectable and implantable systems under the trade name Biochronomer.
o Advanced Magnetics Inc., of ...